Skip to main content

Raúl Méndez: "We have discovered a cancer switch"

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

"La Vanguardia" journalist Josep Corbella holds a long interview with IRB Barcelona researcher Raúl Méndez about his breakthrough on the relation between CPEB proteins and cancer. This study is one of eight participating in the competition "Vanguardia de la ciencia", run by “La Vanguardia” and the Catalunya La Pedrera Foundation.

Vote for the research performed by Raúl Méndez

Read the interview with Raúl Méndez in La Vanguardia (PDF in Spanish, PDF in Catalan)

Related news:

24 February 2013
Researchers at IRB discover a general mechanism that accelerates tumor development

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).